Beximco Pharmaceuticals (DHA:BXPHARMA) Days Sales Outstanding : 29.61 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Days Sales Outstanding?

Beximco Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2023 was BDT3,539 Mil. Beximco Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was BDT10,904 Mil. Hence, Beximco Pharmaceuticals's Days Sales Outstanding for the three months ended in Dec. 2023 was 29.61.

The historical rank and industry rank for Beximco Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

DHA:BXPHARMA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 29.43 Med: 42.53 Max: 51.01
Current: 40.4

During the past 13 years, Beximco Pharmaceuticals's highest Days Sales Outstanding was 51.01. The lowest was 29.43. And the median was 42.53.

DHA:BXPHARMA's Days Sales Outstanding is ranked better than
79% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.115 vs DHA:BXPHARMA: 40.40

Beximco Pharmaceuticals's Days Sales Outstanding increased from Sep. 2022 (28.95) to Dec. 2023 (29.61).

Beximco Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Beximco Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Days Sales Outstanding Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

48.76

45.77

35.98

29.95

29.43

Beximco Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															28.95	30.19	30.68	29.54	29.61

Competitive Comparison of Beximco Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beximco Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Days Sales Outstanding falls into.

Beximco Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Beximco Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (2963.144	+	3369.996)	/	2 )	/	39266.662	*	365
=	3166.57					/	39266.662	*	365
=	29.43

Beximco Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3369.996	+	3707.317)	/	2 )	/	10904.211	*	365 / 4
=	3538.6565					/	10904.211	*	365 / 4
=	29.61

Beximco Pharmaceuticals (DHA:BXPHARMA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Beximco Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines